Cited by 172Immunotherapy and Immune ResponsesT-cell and B-cell ImmunologyImmune Response and Inflammation

Butyrate interferes with the differentiation and function of human monocyte-derived dendritic cells

Liu, Lu, Li, Lin, Min, Jun, Wang, Jie, Wu, Heng, Zeng, Yujie, Chen, Shuang, Chu, Zhonghua·2012·Cellular Immunology

Abstract

Dendritic cells (DCs) are specialized antigen-presenting cells that are uniquely capable of either inducing immune responses or maintaining a state of self-tolerance, depending on their stage of maturation. In the present study, we describe a way to interfere with DCs maturation. The compound butyrate can affect the differentiation of DCs generated from human monocytes and can inhibit T cell proliferation. We demonstrate that butyrate substantially down-regulates the expression of CD80, CD83, and MHC class II molecules; increases endocytic capability; reduces allostimulatory abilities; promote interleukin-10 (IL-10) production; and inhibits interleukin-12 (IL-12) and interferon-γ (IFN-γ) production. These results demonstrate a specific immune suppression property of butyrate and supports further investigation for butyrate as a new immunotherapeutic agent.

Integrity signals

Registry

Crossref · 10.1016/j.cellimm.2012.05.011

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The citation lists haven’t been fetched yet

References 40 · Cited by 172

Authors
Liu, L., Li, L., Min, J., Wang, J., Wu, H., Zeng, Y., Chen, S., & Chu, Z.
Affiliations
Sun Yat-sen University (CN)
Corresponding author
Chu, Zhonghua
Venue
Cellular Immunology
Publisher
Elsevier BV
Published
2012-05
Volume
277
Issue
1-2
Pages
66-73
ISSN
0008-8749 (ISSN-L)
OpenAlex
W1975488300
Cited by
172
References
40
Citations by year
2026: 15 · 2025: 20 · 2024: 21 · 2023: 24 · 2022: 12 · 2021: 21 · 2020: 16 · 2019: 16 · 2018: 5 · 2017: 7 · 2016: 7 · 2015: 4 · 2014: 1 · 2013: 3
FWCI
1.11
Type
journal article
Language
en
Open access
closed
Locations
  • Cellular Immunology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Natural Science Foundation of China
  • Sun Yat-sen University
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Keywords
butyrate, dendritic cells, monocyte-derived dendritic cells, dendritic cell maturation, immunosuppression, T cell proliferation, CD80, CD83, MHC class II, endocytosis, allostimulation, IL-10, IL-12, interferon-gamma, antigen presentation, immunotherapy
MeSH terms
CD83 Antigen, Butyrates, Cell Differentiation, Cells, Cultured, Dendritic Cells, Endocytosis, HLA-DR Antigens, Humans, Immunoglobulins, Immunosuppression Therapy, Membrane Glycoproteins, Monocytes, Down-Regulation, Antigens, CD, Cytokines, B7-1 Antigen

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review